IBD 50 Stock Doximity Rockets And Eyes A Breakout After Walloping Earnings Views
Doximity, which ranks fifth on the IBD 50, crushed December-quarter expectations late Thursday and raised its outlook for the ...
IBD Stock Of The Day CRH Scores Breakout On Stake Sale
Construction materials supplier CRH cleared a buy point Thursday after announcing plans to unload its stake in SigmaRoc.
Intestinal worms could hold key to treating inflammatory bowel disease
A four year-long research study has found that particles secreted by an intestinal worm may assist in treating inflammatory ...
Investor's Business Daily on MSN7h
Kemper Stock Gets IBD Rating Upgrade
This unique rating measures technical performance by showing how a stock's price movement over the last 52 weeks compares to ...
The Brighterside of News on MSN8h
Keto diet improves multiple sclerosis, IBD and arthritis symptoms
Diet plays a pivotal role in influencing autoimmune diseases like multiple sclerosis (MS), inflammatory bowel disease, and ...
Mozart Therapeutics Presents Compelling New Preclinical Data on MTX-201 at the 2025 Crohn's and Colitis Congress®
Mozart Therapeutics, the leading developer of CD8 Treg network modulators in autoimmune disease, announces the presentation ...
HealthDay on MSN20h
Inflammatory Bowel Disease Tied to Higher Risk for Heart Disease
Male patients with inflammatory bowel disease (IBD) face a higher risk for ischemic heart diseases (IHDs), according to a study published in the March issue of the International Journal of Cardiology ...
Societe Generale 4Q Rev EUR6.62B
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...